槲皮素
二甲双胍
糖尿病肾病
医学
肾病
抗氧化剂
内科学
药理学
仓鼠
内分泌学
糖尿病
化学
生物化学
作者
Soha Shebel Nassar,M. A. Sadek,Huda Ismail,Gehan Salah El-Din Moram
出处
期刊:Journal of pharmaceutical research international
[Sciencedomain International]
日期:2021-06-29
卷期号:: 140-153
被引量:1
标识
DOI:10.9734/jpri/2021/v33i33b31805
摘要
Aims: The aim of this study is to examine the regulatory effects of quercetin nanoparticles (QNPs) compared with native quercetin either with or without metformin against the abnormal molecular and biochemical pathways that eventually culminate in the pathologic condition clinically known as diabetic nephropathy (DN) in hamsters
Methodology: After synthesis and characterization of the QNPs, seventy male adult hamsters are divided as following; G1:healthy control, G2:untreated DN hamsters, G3:DN+metformin G4:DN+native quercetin, G5:DN+QNPs, G6:DN+native quercetin+ metformin and G7: DN + QNPs + metformin.
Results: Our results illustrated that the effect of QNPs + metformin is the most effective in IRS-1 and GLUT-4 gene expression that correlated with inhibition of HDACs which in turn improved diabetic and nephropathy biomarkers, this effectiveness followed by G6 then G3 and finally G4 after G5. These results were confirmed by immunohistochemical examinations. Levels of antioxidant and inflammatory biomarkers also reflected the protective effect of our treatments.
Conclusion: All tested treatments significantly exhibit renal improvement.
科研通智能强力驱动
Strongly Powered by AbleSci AI